Brief summary

Prospective, non-randomized, multi-center study assessing the long term safety and efficacy of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected left main coronary artery disease.

Primary endpoints

  • Clinical Endpoint: Target Lesion Failure at 12 months post-procedure
  • Efficacy Endpoint: Angiographic success at 12 months post-procedure: Achievement of <20% final residual stenosis at target lesion (visual estimation) with TIMI 3 flow in main branch.

CERC Services

  • Project Management
  • Electronic Data Capture Management
  • Data Management
  • Monitoring
  • CEC activities
  • Core Laboratory
  • Safety Reporting
  • Statistical Activities and Clinical Report


France, Germany, Italy, Poland, Switzerland and The Netherlands managed by CERC.

Center number

18 centers managed by CERC.